FLAG Therapeutics Overview
- Founded
- 2013

- Status
- Private
- Employees
- 5

- Latest Deal Type
- Angel
- Latest Deal Amount
- $72.5K

- Investors
- 1
FLAG Therapeutics General Information
Description
Operator of an oncology company intended to develop a dual-acting small molecule for the treatment of Glioblastoma. The company's therapies are based on two investigational product platforms--the Anti-angiogenic/Anti-tubulin (AA/AT) platform and Folate-target Anti-cancer (FTAC) platform that include multiple water-soluble small molecule compounds, enabling doctors to treat multiple cancer types including brain, lung, ovarian and pancreatic.
Contact Information
- 9168 Wooden Road
- Raleigh, NC 27617
- United States
FLAG Therapeutics Timeline
FLAG Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Angel (individual) | 01-Jul-2019 | $72.5K | 00.000 | Completed | Generating Revenue | |
3. Seed Round | 09-Jan-2019 | 00.00 | 00.000 | 000.00 | Completed | Startup |
2. Grant | 01-Jan-2017 | $1.5M | $250K | Completed | Startup | |
1. Debt - General | 06-Mar-2015 | $250K | $250K | Completed | Startup |
FLAG Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed | 0,000,000 | 00.0 | 00.0 | 00 | 00.0 | 00.00 |
FLAG Therapeutics Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Frank Sorgi Ph.D | Founder, President & Chief Executive Officer |
FLAG Therapeutics Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
Frank Sorgi Ph.D | FLAG Therapeutics | Founder, President & Chief Executive Officer | 000 0000 |
FLAG Therapeutics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialFLAG Therapeutics Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 |